WASHINGTON, D.C. 20549
(Amendment No. 1)
Securities registered pursuant to Section 12(g) of the Act: None.
Indicate by check if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
Indicate by check if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the
definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over
financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The aggregate market value of common stock held by non-affiliates of the registrant was $9.2 million, based on the closing share price as reported on the New York Stock
Exchange on June 30, 2020 and the assumption that all Directors and executive officers of the registrant and their families and beneficial holders of 10% of the registrant's common stock are affiliates. This determination of affiliate status is not
necessarily a conclusive determination for any other purpose.
As of February 26, 2021, 2,048,319 shares of our common stock were outstanding (excluding 1,359,600 shares held as treasury stock).
Altisource Asset Management Corporation (“we,” “us,” “our,” or the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its
Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “Original Form 10-K”), which was originally filed with the Securities and Exchange Commission (the “SEC”) on March 3, 2021 solely to include the information required in
Part III (Items 10, 11, 12, 13 and 14) of Form 10-K that was previously omitted from the Original Form 10-K. Except as expressly set forth herein, this Amendment does not reflect events occurring after the date of the Original Form 10-K or modify
or update any of the other disclosures contained in the Original Form 10-K in any way. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and our other filings with the SEC. This Amendment consists solely of the
preceding cover page and table of contents, this explanatory note, Part III (Items 10, 11, 12, 13 and 14), the signature page and the certifications required to be filed as exhibits to this Amendment.
Item 10. Directors, Executive Officers and Corporate Governance.
Our Directors and executive officers are as follows:
|
|
|
|
|
Indroneel Chatterjee
|
|
40
|
|
Chief Executive Officer and Chairman
|
Ricardo C. Byrd
|
|
71
|
|
Director
|
John A. Engerman
|
|
51
|
|
Director
|
John P. de Jongh, Jr.
|
|
62
|
|
Director
|
Christopher Moltke-Hansen
|
|
34
|
|
Chief Financial Officer
|
P. Graham Singer
|
|
40
|
|
General Counsel and Secretary
|
(1) |
Except as otherwise indicated, all information set forth herein is as of April 15, 2021, and all stock ownership and equity award information for Messrs. Chatterjee,
Moltke-Hansen and Singer are based solely upon their Form 4 filings with the SEC.
|
Indroneel Chatterjee. Mr. Chatterjee became our Co-Chief Executive Officer and has served as
a member of our Board of Directors on January 13, 2020, and Chairman of our Board since August 13, 2020, and Chief Executive Officer since December 31, 2020. Mr. Chatterjee was terminated as Chief Executive Officer for cause on April 16, 2021 and
was deemed to have resigned as a director and Chairman on that date as well. Prior to joining AAMC, Mr. Chatterjee served as a consultant to various businesses since March 2019. He previously served as Senior Vice President, New Business
Initiatives of Altisource Solutions, Inc. from September 2018 to March 2019. Altisource Solutions, Inc. is a subsidiary of Altisource Portfolio Solutions S.A. (“ASPS”), an integrated service provider and marketplace for the real estate and
mortgage industries. Mr. Chatterjee served as Chief Financial Officer of ASPS from October 2017 to August 2018. Prior to joining ASPS, he served as Head of Credit Solutions, Global Markets at Nomura Securities, an investment banking firm, from
January 2017 to September 2017 and as Executive Director on the fixed income trading desk at Nomura from August 2014.
Ricardo C. Byrd. Mr. Byrd was elected to our Board of
Directors in June 2015. Mr. Byrd has served as the Executive Director of the National Association of Neighborhoods ("NAN"), one of the nation’s largest and oldest multi-issue membership associations of grass-roots neighborhood organizations,
since 1995, and from 1982 to 1994, served as Federal FTA Project Manager for NAN. He has over thirty years of management experience in directing grass-roots programs. On America’s social and economic development challenges, he has served as a
public policy catalyst, a community outreach strategist and resource person to the White House, Congressional, state and local government officials, corporations and neighborhood leaders. Mr. Byrd is a native Washingtonian, educated in the
District of Columbia Public Schools, and holds a Bachelor of Arts degree from Howard University.
Mr. Byrd’s understanding of neighborhood and borrower needs will provide us with valuable inputs regarding borrower and tenant satisfaction. His diverse
experience will further enable the Company to consider other client opportunities and their related benefits.
John A. Engerman. Mr. Engerman was elected to our Board of Directors in June 2019. Since 2019,
Mr. Engerman has been Chief Executive Officer and Chairman of The Strategy Group VI, a professional services firm in St. Thomas, and has continued to serve in that role since March 2020 following its acquisition of BDO USVI, LLC (“BDO USVI”), a
full-service accounting and advisory services firm located in St. Thomas, USVI. From July 2016 to March 2020, Mr. Engerman was Managing Partner of BDO USVI. From 2017 to 2018, Mr. Engerman served as the Territorial Campaign Manager for the
successful Albert Bryan and Tregenza Roach Gubernatorial Team for the U.S. Virgin Islands. From January 2014 to June 2016, Mr. Engerman was Executive Vice President, Finance & Planning for International Capital & Management Company, a
finance and analytics firm located in St. Thomas, USVI. From February 2001 to January 2014, Mr. Engerman was a Managing Member of ARI Group, LLC, a government and business advisory firm located in Fort Washington, MD. Mr. Engerman commenced his
career in various accounting, auditing and advisory roles for PricewaterhouseCoopers, Ernst & Young and Capgemini (now part of Ernst & Young). Mr. Engerman also served for five years in the United States Navy. Mr. Engerman holds a
Bachelor degree in Business Administration - Accounting from Howard University in Washington, DC and is a Certified Public Accountant.
Mr. Engerman brings extensive finance and accounting experience to the Board that enables him to provide valuable insight to the Audit Committee and
guidance to the Board in overseeing the financial reporting and accounting aspects of our business.
John P. de Jongh, Jr. John P. de Jongh, Jr., the former Governor of the United States Virgin
Islands, was appointed to our Board of Directors in December 2016. Governor de Jongh currently is a Principal of Chilmark Advisory, LLC (“Chilmark”), a U.S. Virgin Islands-based advisory firm with a focus on real estate, insurance and financial
services. From January 2007 to January 2015, Governor de Jongh served two terms as the Governor of the U.S. Virgin Islands, during which he led the territory through the difficult economic periods following the financial crisis of 2008, sponsored
legislation to expand access of small businesses to loan programs and export initiatives, ensured Government access to capital markets, negotiated public-private initiatives with cruise lines and rum producers and implemented revitalization
projects for St. Croix, St. Thomas and St. John. From 2003 to 2006, Governor de Jongh served as a Principal of Chilmark in the same capacities as his current position. From 1992 to 2002, Governor de Jongh served as President, Chief Operating
Officer and a member of the board of directors of Lockhart Companies Incorporated, a holding company with subsidiaries in real estate, insurance and financial services in the U.S. Virgin Islands, the British Virgin Islands and the Turks &
Caicos. He also served three terms as the President of the St. Thomas-St. John Chamber of Commerce and the Community Foundation of the Virgin Islands, a philanthropic organization focused on children and families. From 1993 to 1995, he was a
Senior Managing Consultant for Public Financial Management, Inc., where he implemented five-year strategic plans for the cities of Philadelphia, PA, New Haven, CT and Washington, DC. Prior to 1993, Governor de Jongh served in multiple capacities
for the Government of the U.S. Virgin Islands, including Commissioner of Finance, Director of Finance for the Virgin Islands Finance Authority, Executive Assistant to the Governor and Chairman of the Virgin Islands Water and Power Authority.
Governor de Jongh received his Bachelor of Arts in Economics from Antioch College.
Governor de Jongh’s substantial political and business experience in the U.S. Virgin Islands, as well as his financial and real estate-related experience
in general, bring strong targeted knowledge to our Company and drive a diverse and local understanding to our Board of Directors for the jurisdiction in which we are located.
Chris Moltke-Hansen. Mr. Moltke-Hansen has served as our Chief Financial Officer since
January 2021. Mr. Moltke-Hansen joined the Company in 2018 and was subsequently promoted to Managing Director of Finance in October 2020. Mr. Moltke-Hansen resigned as Chief Financial Officer on April 24, 2021. In his previous positions with the
Company, Mr. Moltke-Hansen was responsible for managing the Company’s financial and SEC reporting and the accounting policies of the Company and its primary client, Front Yard. Prior to joining AAMC in 2018, Mr. Moltke-Hansen was Vice President
of Financial Control at Credit Suisse, a leading global wealth manager and investment bank, which he joined in 2011 and where he held various positions of increasing responsibility.
P. Graham Singer. Mr. Singer has served as our
General Counsel & Secretary since January 2021. Mr. Singer resigned as General Counsel on April 23, 2021. Since joining the Company in April 2018, Mr. Singer has overseen a broad range of responsibilities including corporate structuring and
consolidation, management and oversight of outside counsel specific to all real estate acquisitions and dispositions, and various real estate and property management activities, including loan extensions, modifications, and property-related
litigation. Prior to joining the Company, Mr. Singer served as Legal Counsel for VEREIT, Inc. where he was responsible for all aspects of the acquisition and disposition of real estate assets totaling greater than $2.5 billion in acquisitions and
$550M in dispositions.
None of our Directors and/or executive officers is related to any other Director and/or executive officer of AAMC or any of its subsidiaries by blood,
marriage or adoption.
Board of Directors
Our Amended and Restated Bylaws provide that our Board of Directors shall consist of no less than three (3) members with the exact number to be determined
by vote of a majority of the Board of Directors. As of April 15, 2021, our Board of Directors consisted of four (4) members.
Meetings of the Board of Directors
The Board plays an active role in overseeing management and representing the interests of the stockholders. Directors are expected to attend all meetings
of the Board and the meetings of committees on which they serve. Directors are also consulted for advice and counsel between formal meetings. Our current Board held seventeen (17) meetings in 2020. Each incumbent Director attended at least 75% of
the aggregate of (1) the total number of Board meetings in 2020 held during the period for which they were a Director and (2) the total number of meetings in 2020 of all committees of our Board on which the Director served during the periods they
served. The Board also regularly held executive sessions of the independent directors. We do not have a formal policy regarding Director attendance at the Annual Meetings of Stockholders. However, all of the incumbent members of our Board
attended our 2020 Annual Meeting of Stockholders.
Independence of Directors
Our Corporate Governance Guidelines provide that our Board must be comprised of a majority of Directors who qualify as independent Directors under the
standards of the New York Stock Exchange (the “NYSE”), which governs the NYSE American where our common stock is listed.
Our Board annually reviews the direct and indirect relationships that we have with each Director. The purpose of this review is to determine whether any
such transactions or relationships are inconsistent with a determination that the Director is independent. Only those Directors who are determined by our Board to have no material relationship with the Company are considered independent. This
determination is based in part on the analysis of questionnaire responses that follow the independence standards and qualifications established by NYSE rules and law. Our current Board has determined that Messrs. Byrd, Engerman, and Governor de
Jongh are independent Directors and were independent Directors for their full 2020-2021 service year.
Board Leadership Structure
Our Board of Directors’ leadership structure consists of a Chairman who is also our Chief Executive Officer, a Lead Independent Director, who is elected
by the independent directors, and three Committee Chairs, each of whom are independent directors (and one of whom, the Chair of our Audit Committee, is also our Lead Independent Director). We discuss succession planning with respect to our
Chairman, our Chief Executive Officer, and other business heads at least annually.
Our Board has combined the positions of Chairman and Chief Executive Officer since June 2015, with Mr. Chatterjee serving as Chairman of the Board and
Chief Executive Officer of the Company since his appointment in January 2020 until April 16, 2021. Due to the respective combined positions as Chairman and Chief Executive Officer, we have had a Lead Independent Director while the Chief Executive
Officer holds both positions. Except for Mr. Chatterjee, all of our other Directors are independent, and all of our Board committees and their chairpersons are independent. Our Board believes that the strong leadership structure provides the
Board with important balance and knowledge base, for several reasons. First, a combined Chairman and Chief Executive Officer position allows us to speak with one voice to our stockholders, counterparties and external constituencies. Second, we
have a strong Lead Independent Director who provides independent oversight over the Chairman and Chief Executive Officer and the full Board of Directors, including with respect to the calling of meetings of the Board, executive sessions of the
independent members of the Board, and setting the agenda for meetings of the Board and meetings of the independent members of the Board. Our Lead Independent Director has provided important leadership and insight while also serving as the Chair
of our Audit Committee. We also have empowered our other strong independent Directors to chair our Compensation Committee and Nomination/Governance Committee. Each of our independent Directors is authorized to call executive sessions of
independent Directors to discuss any subject. Our independent Directors also frequently communicate with each other by telephone between meetings of the Board and committees of the Board on an ad hoc basis as needed.
Our Board believes that this leadership structure provides an effective balance between leadership of the Board and our Company by a strong Chairman and
Chief Executive Officer and effective oversight of the Board and our Company by independent Directors.
Committees of the Board of Directors
Our Board has established an Audit Committee, a Compensation Committee and a Nomination/Governance Committee. A brief description of these committees is
provided below.
Audit Committee. The Audit Committee of our Board oversees the relationship with our
independent registered public accounting firm, reviews and advises our Board with respect to reports by our independent registered public accounting firm and monitors our compliance with laws and regulations applicable to our operations,
including the evaluation of significant matters relating to the financial reporting process and our system of accounting, internal controls, auditing and federal securities law matters and the review of the scope and results of the annual audit
conducted by the independent registered public accounting firm.
The members of the Audit Committee since October 2020 have been Governor de Jongh, and Messrs. Byrd and Engerman. Governor de Jongh has served as the
Chair of the Audit Committee since May 2018. For the 2021-2022 service year, Governor de Jongh is expected to continue to serve as the Chair of the Audit Committee, and Messrs. Byrd and Engerman will continue to serve as a member of the Audit
Committee. Each member of our Audit Committee is independent as defined in regulations adopted by the SEC and NYSE listing standards. Our Board has determined that, throughout the 2020-2021 service year, all members of our Audit Committee are,
and have been, “financially literate” as defined in SEC rules. Our Board has also determined that each of Mr. Engerman and Governor de Jongh qualifies as an “audit committee financial expert” as that term is defined in SEC rules.
Our Audit Committee operates under a written charter approved by our Board of Directors, a copy of which is available on our website at
www.altisourceamc.com and is available in print to any stockholder who requests it. On an annual basis, the Audit Committee reviews and approves its charter. The Audit Committee also evaluates its performance under its charter annually and
delivers a report to the Board setting forth the results of its evaluation, including an assessment of the adequacy of its charter and any recommendations for amendments. The Audit Committee met seven (7) times in 2020.
Compensation Committee. The Compensation Committee of our Board oversees our Board and
employee compensation and employee benefit plans and practices. The Compensation Committee also evaluates and makes recommendations to our Board for human resource and compensation matters relating to our named executive officers (“NEOs”). With
respect to all officers and employees of the Company other than the Chairman/Chief Executive Officer, the Compensation Committee reviews with the Chief Executive Officers and subsequently approves all executive compensation plans, any executive
severance or termination arrangements and any equity compensation plans that are not subject to stockholder approval. The Compensation Committee also has the power to review our other compensation plans, including the goals and objectives thereof
and to recommend changes to these plans to our Board. The Compensation Committee has authority for the administration of awards under AAMC’s 2012 Equity Incentive Plan (the “2012 Equity Plan”), and the 2020 Equity Incentive Plan (the “2020 Equity
Plan”). The Compensation Committee has the authority to retain independent counsel or other advisers as it deems necessary in connection with its responsibilities at our expense. The Compensation Committee may request that any of our Directors,
officers or employees, or other persons attend its meetings to provide advice, counsel or pertinent information as the Compensation Committee requests.
The members of the Compensation Committee in 2020 were Messrs. Byrd, Engerman and Governor de Jongh, with Mr. Engerman serving as the Chair of the
Compensation Committee since June 2019., Mr. Engerman is expected to continue to serve as the Chair of the Compensation Committee, and Mr. Byrd and Governor de Jongh is expected to continue to serve as Compensation Committee members. Each member
of the Compensation Committee is independent as defined by NYSE listing standards. While we have no specific qualification requirements for members of the Compensation Committee, our members have knowledge and experience regarding compensation
matters as developed through their respective business experience in both management and advisory roles, including general business management, executive compensation and employee benefits experience.
Our Compensation Committee operates under a written charter approved by our Board, a copy of which is available on our website at www.altisourceamc.com
and is available in print to any stockholder who requests it. On an annual basis, the Compensation Committee reviews and approves its charter. The Compensation Committee also evaluates its performance under its charter annually and delivers a
report to the Board setting forth the results of its evaluation, including an assessment of the adequacy of its charter and any recommendations for amendments. The Compensation Committee met seven (7) times in 2020.
Compensation Committee Interlocks and Insider Participation: There were no interlocks during 2020.
Nomination/Governance Committee. The
Nomination/Governance Committee of our Board makes recommendations to our Board of individuals qualified to serve as Directors and committee members for our Board; advises our Board with respect to Board composition, procedures and committees;
develops and recommends to the Board a set of corporate governance principles; and oversees the evaluation of our Board and our management.
The members of the Nomination/Governance Committee since October 2020 were Messrs. Byrd, Engerman, and Governor de Jongh. Mr. Byrd has served as the Chair
of the Nomination/Governance Committee since May 2017. For the 2021-2022 service year, Mr. Byrd is expected to continue to serve as Chair of the Nomination/Governance Committee, and Mr. Engerman and Governor de Jongh are expected to continue to
serve as members of the Nomination/Governance Committee. Each member of our Nomination/Governance Committee is independent as defined in the NYSE listing standards.
Our Nomination/Governance Committee operates under a written charter approved by our Board of Directors, a copy of which is available on our website at
www.altisourceamc.com and is available in print to any stockholder who requests it. On an annual basis, the Nomination/Governance Committee reviews and approves its charter. The Nomination/Governance Committee also evaluates its performance under
its charter annually and delivers a report to the Board setting forth the results of its evaluation, including an assessment of the adequacy of its charter and any recommendations for amendments. The Nomination/Governance Committee met two (2)
times in 2020.
It is the policy of our Nomination/Governance Committee to consider candidates for Director recommended by our stockholders. In evaluating all nominees
for Director, our Nomination/Governance Committee will take into account the applicable requirements for Directors under the Exchange Act and NYSE listing standards. In addition, our Nomination/Governance Committee will take into account AAMC’s
best interests as well as such factors as knowledge, experience, skills, expertise, diversity and the interplay of the candidate’s experience with the background of other members of our Board of Directors.
The Nomination/Governance Committee will consider diversity when it recommends Director nominees to the Board of Directors, viewing diversity in an
expansive way to include differences in prior work experience, viewpoint, education and skill set. In particular, the Nomination/Governance Committee will consider diversity in professional experience, skills, expertise, training, broad-based
business knowledge and understanding of our business environment when recommending Director nominees to the Board of Directors, with the objective of achieving a Board with diverse business and educational backgrounds. Board members should have
individual backgrounds that, when combined, provide a portfolio of experience and knowledge that will serve our governance and strategic needs. The Nomination/Governance Committee will periodically review the skills and attributes of Board
members within the context of the current make-up of the full Board as the Nomination/Governance Committee deems appropriate.
The Nomination/Governance Committee will regularly assess the appropriate size of the Board and whether any vacancies on the Board are anticipated.
Various potential candidates for Director will then be identified. Candidates may come to the attention of the Nomination/Governance Committee through current members of the Board, professional search firms, stockholders or industry sources.
In connection with this evaluation, one or more members of the Nomination/Governance Committee, and others as appropriate, will interview prospective
nominees. After completing this evaluation and interview, the Nomination/Governance Committee will make a recommendation to the full Board as to the persons who should be nominated by the Board. The Board will determine the nominees after
considering the recommendation and report of the Nomination/Governance Committee. Should a stockholder recommend a candidate for Director, our Nomination/Governance Committee would evaluate such candidate in the same manner that it evaluates any
other nominee.
A stockholder who wants to recommend persons for consideration by our Nomination/Governance Committee as nominees for election to our Board, can do so by
writing to our Corporate Secretary at Altisource Asset Management Corporation, 5100 Tamarind Reef, Christiansted, United States Virgin Islands 00820. The recommendation should provide each proposed nominee’s name, biographical data and
qualifications. The recommendation should also include a written statement from the proposed nominee consenting to be named as a nominee and, if nominated and elected, to serve as a Director.
Corporate Governance Guidelines
The Corporate Governance Guidelines adopted by our Board provide guidelines for us and our Board to ensure effective corporate governance. The Corporate
Governance Guidelines cover topics such as Director qualification standards, Board and committee composition, Director responsibilities, Director access to management and independent advisors, Director compensation, Director orientation and
continuing education, management succession and annual performance appraisal of the Board.
Our Nomination/Governance Committee reviews our Corporate Governance Guidelines at least once a year and, if necessary, recommends changes to our Board.
Our Corporate Governance Guidelines are available on our website at www.altisourceamc.com and are available to any stockholder who requests them by writing to our Corporate Secretary at Altisource Asset Management Corporation, 5100 Tamarind Reef,
Christiansted, United States Virgin Islands 00820.
Executive Sessions of Non-Management Directors
Non-management Directors meet in executive session without management representatives periodically.
Communications with Directors
If a stockholder should desire to contact our Board or any individual Director regarding AAMC, he or she may do so by mail addressed to our Corporate
Secretary at Altisource Asset Management Corporation, 5100 Tamarind Reef, Christiansted, United States Virgin Islands 00820. All stockholder communications received in writing will be distributed to our full Board if addressed to the full Board
or to individual Directors if addressed to any of them individually.
Code of Ethics
We adopted a Code of Business Conduct and Ethics that applies to our Directors, executive officers and employees (including our principal executive
officer). We also adopted a Code of Ethics for Senior Financial Officers that applies to our principal financial officer and principal accounting officer. Any waivers from the Code of Business Conduct and Ethics or the Code of Ethics for Senior
Financial Officers must be approved by our Board or the Audit Committee and will be subsequently disclosed when required by SEC or applicable exchange rules. Our Nomination/Governance Committee reviews our Code of Business Conduct and Ethics and
the Code of Ethics for Senior Financial Officers at least once a year and, if necessary, recommends changes to our Board. The Code of Business Conduct and Ethics and the Code of Ethics for Senior Financial Officers are available on our website at
www.altisourceamc.com and are available to any stockholder who requests a copy by writing to our Corporate Secretary at Altisource Asset Management Corporation, 5100 Tamarind Reef, Christiansted, United States Virgin Islands 00820. Any amendments
to the Code of Business Conduct and Ethics or the Code of Ethics for Senior Financial Officers, as well as any waivers that are required to be disclosed under SEC or exchange rules, will either be posted on our website at www.altisourceamc.com or
otherwise disclosed in accordance with such rules.
Risk Management and Oversight Process
Our Board and each of its committees are involved with the oversight of the Company’s risk management.
The Board and the Audit Committee oversee AAMC’s credit risk, liquidity risk, regulatory risk, operational risk and enterprise risk by regular reviews
with management and internal and external auditors. In its periodic meetings with internal and external auditors, the Audit Committee discusses the scope and plan for the internal audit and includes management in its review of accounting and
financial controls, assessment of business risks and legal and ethical compliance programs.
In its periodic meetings with the external auditors, the Audit Committee discusses the external audit scope, the external auditors’ responsibility under
the standards of the Public Company Accounting Oversight Board (“PCAOB”), accounting policies and practices and other required communications. In addition, through regular reviews with management and, at times, certain employees of AAMC, the
Nomination/Governance Committee assists the Board in overseeing the Company’s governance and succession risks, and the Compensation Committee assists the Board in overseeing our compensation policies and related risks.
The Board's role in risk oversight is consistent with the Company’s leadership structure, with the Chief Executive Officer and other members of senior
management having responsibility for assessing and managing the Company’s risk exposure, and the Board and its committees providing oversight in connection with these efforts. Our Investment Committee, which is comprised of our Lead Independent
Director and our Chief Executive Officer, has responsibility for assessing and managing the Company’s risk exposure with respect to transactional and counterparty risk.
Delinquent Section 16(a) Reports
Section 16(a) of the Exchange Act requires our executive officers, Directors and persons who beneficially own more than 10% of our common stock to file
reports of ownership and changes in ownership with the SEC. Executive officers, Directors and greater than 10% stockholders are required by SEC regulations to furnish us with copies of all Section 16(a) forms they file.
Based upon the Company’s review of Section 16(a) reports and related written representations, the Company believes that with the exception of Chris
Moltke-Hansen and P. Graham Singer, who upon appointment as executive officers on January 1, 2021, submitted their initial Form 3 filings one day late on January 12, 2021 due to challenges attributable to the COVID-19 pandemic, and Indroneel
Chatterjee, who submitted a Form 4 filing reporting one tax withholding transaction ten days late on February 16, 2021, all of the Company’s reporting persons complied with their Section 16(a) filing requirements in 2020.
Item 11. Executive Compensation.
This section discusses the material components of our executive compensation program for our NEOs. We believe an effective executive compensation program
aligns executives’ interests with stockholders by rewarding performance designed to increase stockholder value. We seek to promote individual service longevity and to provide our executives with long-term incentive opportunities that promote
consistent, high-level performance. The Compensation Committee evaluates both performance and compensation annually to ensure that we maintain our ability to attract and retain superior employees in key positions and that compensation provided to
key employees remains competitive relative to the compensation paid to similarly situated executives of peer companies, subject to consideration of the Company’s own financial performance. To achieve these objectives, we generally believe
executive compensation packages should include both cash and equity-based compensation that rewards performance as measured against established goals.
For 2020, our NEOs and their positions as of December 31, 2020 were as follows:
|
• |
Indroneel Chatterjee, Chief Executive Officer
|
|
• |
George G. Ellison, Former Chief Executive Officer
|
|
• |
Robin N. Lowe, Chief Financial Officer
|
|
• |
Stephen H. Gray, General Counsel and Secretary
|
Elements of Compensation
The current compensation package for our NEOs consists of base salary and annual cash incentive compensation. This compensation structure was developed in
order to provide each NEO with a competitive salary while emphasizing a cash incentive compensation element that is tied to the achievement of corporate goals and strategic initiatives as well as individual performance. The Compensation Committee
also may, from time to time, grant equity compensation awards to the NEOs in order to further align their interests with AAMC’s stockholders. We believe that the following elements of compensation are appropriate in light of our strategic
initiatives, industry, current challenges and environment.
Base Salary. Base salaries for our NEOs are established based on individual qualifications
and job responsibilities while taking into account compensation levels at similarly situated companies for similar positions.
Base salaries of the NEOs are expected to be reviewed annually during the performance appraisal process with adjustments made based on market information,
internal review of the executive officer’s compensation in relation to other officers, the individual performance of the executive officer and our corporate performance. Salary levels are also considered upon a promotion or other change in job
responsibility. Salary adjustment recommendations will be based on our overall performance and an analysis of compensation levels necessary to maintain and attract quality personnel. The Compensation Committee will set the base salary for the
Chief Executive Officer and approve the base salaries for all other NEOs.
Annual Cash Incentive Compensation. Pursuant to our annual incentive philosophy, our
executives can earn cash awards as determined by the Compensation Committee. Our philosophy provides the Compensation Committee and our management with the authority to establish incentive award guidelines, which are further discussed below.
Equity Awards. The Company adopted the 2020 Equity Incentive Plan, which superseded the 2012
Equity Incentive Plan (together with the 2012 Equity Incentive Plan, the "Equity Incentive Plans"), to afford an incentive to officers, non-employee directors, employees, advisors and consultants of the Company and its affiliates to continue as
officers, non-employee directors, employees, advisors or consultants, to increase their efforts on behalf of AAMC and to promote the success of AAMC’s business. From time to time, the Compensation Committee, as administrator, grants awards to our
NEOs in addition to their annual cash incentive compensation.
Employee Relocation Program. In order to enable us to recruit top talent and incentivize key
personnel to relocate, we offer a relocation package to individuals who are relocating to the U.S. Virgin Islands, and prior to 2021, the Cayman Islands, to work (the “Employee Relocation Program”). The Employee Relocation Program includes
relocation benefits such as moving expenses, home sale support, a housing allowance, payment of applicable children’s school tuition fees and payment of “home leave” travel for return trips to the continental United States, in each case subject
to certain limits and exceptions. Upon a participant’s departure after at least one year of service or termination without cause, such participant is eligible to receive reimbursement for relocation costs back to the continental United States. We
believe that our Employee Relocation Program is necessary to attract and retain talent that is critical to our success.
2020 Compensation Determinations
Under AAMC’s annual cash incentive compensation plan, our NEOs can earn cash incentive compensation awards as determined by the Compensation Committee.
The Compensation Committee and management have the authority to establish incentive compensation award guidelines. Each NEO has a targeted annual cash incentive award that is expressed as a percentage of his or her annual cash total target
compensation. In 2020, 28-46% of total annual cash target compensation was payable to our NEOs only upon achievement of certain Company and individual performance levels. The appropriate targeted percentage varies based upon the nature and scope
of each NEO’s responsibilities.
Our annual incentive-based cash compensation is structured to motivate executives to achieve key performance objectives by rewarding the executives for
such achievement. We seek to accomplish this by utilizing a balanced methodology that incorporates multiple financial and non-financial performance objectives developed through our annual strategic planning process. The Compensation Committee
also determined that there were certain goals for the Front Yard business being managed by the executive officers given that the achievement of Front Yard's goals would enable Front Yard to meet performance targets that could translate into
higher asset management revenues for AAMC.
For 2020, corporate goals for both Front Yard and AAMC were developed by our Compensation Committee and included targets pertaining to (a) a renegotiation
of the asset management agreement between AAMC and Front Yard in order to provide better termination fee protection to AAMC, prevent the asset management fees from continuing to decrease under the asset management agreement and provide a simpler
market approach in the asset management agreement for AAMC to increase the fees payable to AAMC while enabling Front Yard to achieve general and administrative expense load more in line with industry standards, (b) further optimizing Front Yard’s
debt facilities to cap and/or fix interest rate exposure, (c) completing the internalization of Front Yard's property management of its approximately 8,000 remaining externally managed rental properties on an accelerated basis to ensure Front
Yard’s entire portfolio is internally managed, (d) improving and/or rationalizing the rental property operating metrics of Front Yard, (e) when permitted, adding additional revenue streams to AAMC that do not adversely affect the services
provided to Front Yard under the asset management agreement, and (f) developing options to address the Series A Preferred Stock of AAMC.
This incentive compensation structure is intended to align the goals of our incentive eligible employees with the overall success of AAMC and Front Yard,
as AAMC’s primary client, and ultimately with the interests of our stockholders.
The Company’s Compensation Committee reviewed the recommendation of the Chief Executive Officer with respect to the annual incentive compensation of
Messrs. Lowe and Gray and could determine to amend such annual incentive compensation based on such factors as it determines are appropriate, including market information and individual performance. In coming to his recommendation to the
Compensation Committee regarding the annual incentive compensation for Messrs. Lowe and Gray, the Chief Executive Officer has historically considered those elements of the AAMC executive scorecard that are attributable to Front Yard's and AAMC's
performance. In light of AAMC's focus throughout 2020 on Front Yard's strategic alternatives review process, the integration of all external property management onto Front Yard's internal property management platform and the renegotiation and
amendment of the asset management agreement between Front Yard and AAMC, AAMC did not approve separate executive scorecard metrics attributable to Front Yard's and AAMC's performance for 2020. The Front Yard strategic alternative review process
resulted in the proposed acquisition of Front Yard by affiliates of Amherst Residential, LLC (“Amherst”) pursuant to an Agreement and Plan of Merger, dated as of February 17, 2020. The integration of Front Yard's property management onto the
internal platform was successfully completed well ahead of schedule, and the renegotiation of the asset management agreement resulted in a new amended and restated asset management agreement in May 2019 that addressed the goals of both Front Yard
and AAMC.
In light of the Compensation Committee's review of these important successful initiatives, balanced against the operating challenges faced by Front Yard
following the transfer of more than 12,000 properties onto Front Yard's internal property management platform, the Compensation Committee approved the following cash incentive compensation awards to our NEOs: an annual cash bonus of $947,500 to
Mr. Ellison, or 66.7% of his aggregate target cash bonus opportunity; an annual cash bonus of $350,000 to Mr. Lowe, or 87.5% of his aggregate target cash bonus opportunity; and an annual cash bonus of $315,000 to Mr. Gray, or 71.4 % of his
aggregate bonus opportunity. The Compensation Committee determined to award these bonuses, which were in line with the cash bonuses paid to the executives for 2019 in order to continue to incentivize them, considering the determination that the
compensation to the executives continued to be lower than the median compensation to executives in similar companies, while ensuring that our NEOs' year-end incentive compensation payable by AAMC did not increase from the past three years, due to
the continued challenging financial performance of AAMC. The 2019 year-end bonuses for each of Mr. Ellison and Mr. Lowe were not paid in light of the Front Yard merger transaction not being consummated, and Mr. Gray’s 2019 year-end bonus was paid
in August 2020. Please see the Summary Compensation Table under “Executive Compensation” for the actual amounts awarded to our NEOs for 2019 performance.
The base salary paid and the annual cash incentive compensation approved for our NEOs totaled $3,596,538 in the aggregate for 2020, or approximately 26.2%
of the management fees of $13,712,696 paid by Front Yard to AAMC. Of such $3,596,538 for our NEOs, 55.2% or $1,984,038 was paid as base salary and 44.8% or $1,612,500 was approved in the form of annual cash incentive compensation. $101,845 of the
base salary and $1,012,500 of the annual cash incentive compensation were reimbursed by Front Yard pursuant to the transition plan associated with the termination of the amended and restated asset management agreement with Front Yard.
Employment Agreements
Under his Amended and Restated Employment Agreement, entered into on December 4, 2020, Mr. Chatterjee is entitled to receive an initial annual base salary
of $675,000, subject to annual adjustment by the Compensation Committee, with reduction in salary below such amount only permitted if part of an across-the-board reduction not to exceed 10% of the salaries of all executive officers at the “chief”
level. Mr. Chatterjee is eligible to earn annual cash bonuses beginning with the fiscal year ending December 31, 2020. His target bonus is $1,600,000. His bonus will be subject to the achievement of performance targets established by the
Compensation Committee. He also received a cash signing bonus of $800,000, subject to an obligation to repay 100% of such signing bonus if terminated by the Company for Cause (as defined in the Amended and Restated Employment Agreement) or
without Good Reason (as defined in the Amended and Restated Employment Agreement) within the first year following January 13, 2020 or 50% of such signing bonus if terminated by the Company for Cause or without Good Reason during the second year
following January 13, 2020. Mr. Chatterjee also received an initial equity award outside of the Company’s 2012 Equity Incentive Plan (the “Plan”) but such award will otherwise be subject to the terms and conditions of the Plan. Such initial
equity award was an “inducement award” for purposes of the NYSE American’s exemption from shareholder approval requirements for inducement awards. The equity award consisted of performance-based options to purchase 60,000 shares of common stock
and 60,000 service-based restricted shares. The options are subject to vesting following the achievement of certain trading price targets and further time-based vesting criteria thereafter as further described below in the Outstanding Equity
Awards at 2020 Fiscal Year-End table. The restricted shares will vest annually over a three-year period following the date of grant. Mr. Chatterjee will be entitled to receive additional option awards in connection with certain dilutive issuances
of securities. He is eligible to participate in the Company’s health, life insurance, disability, retirement and other welfare plans on the same terms available to other senior executives. Upon termination of employment, Mr. Chatterjee will be
eligible to receive accrued salary and benefits payable through the date of termination. He will be subject to customary confidentiality and non-disparagement obligations, as well as a twelve-month obligation not to solicit clients, customers or
employees. In addition, if his employment is terminated by the Company for Cause or by Mr. Chatterjee without Good Reason, he will be subject to a twelve-month non-competition obligation. If his employment is terminated by the Company without
Cause or by Mr. Chatterjee for Good Reason, Mr. Chatterjee will be entitled to receive severance equal to the sum of his annual base salary and annual target bonus, payable in twelve month installments, and accelerated vesting of his equity
awards (except as prohibited by the Plan), in each case, subject to his execution of a customary release, providing, among other things, confirmation of his confidentiality, non-disparagement and non-solicitation obligations.
Each of our executives during the 2020 calendar year had executed an Employee Intellectual Property and Confidentiality Agreement at the time they joined
AAMC that contains covenants to maintain our confidential information and that all developments by such executive shall be our property.
2020 Equity Awards
On January 30, 2020, the Compensation Committee awarded Mr. Chatterjee an aggregate of 60,000 shares of AAMC service-based restricted stock with a grant
date fair value of $786,600, which was determined based on the average of the high and low sales price of our common stock on the date of the grant, and 60,000 performance-based stock options with a grant date fair value of $636,733 based on
probable achievement as further described above under “Employment Agreements”. Additionally, the Compensation Committee did not award any of Messrs. Ellison, Lowe or Gray any equity awards in 2020.
In determining the awards for our NEOs, the Compensation Committee considered the valuable and substantial contributions they had made to achieving Front
Yard’s and AAMC’s strategic objectives, the importance to us of retaining and incentivizing them and the desire to have their cash compensation reduced and converted into the restricted stock awards so that the benefits of such grants only would
be realized if the Company’s stock price were to increase.
Stock Ownership Policies
Although we do not have stock ownership requirements, our philosophy is that equity ownership by our Directors and executives is important to attract,
motivate, retain and to align their interests with the interests of our stockholders. The Compensation Committee believes that our various equity incentive plans are adequate to achieve this philosophy. We also maintain an insider trading policy
detailing our trading window period for Directors, executive officers and other employees.
Other Compensation
The Compensation Committee’s policy with respect to other employee benefit plans is to provide benefits to our employees, including executive officers,
that are comparable to benefits offered by companies of a similar size to ours. A competitive comprehensive benefit program is essential to achieving the goal of attracting and retaining highly qualified employees.
Potential Payments upon Termination or Change in Control
Below is a description of the termination benefits payable to the NEOs, except Mr. Indroneel, whose benefits are described above under “Employment
Agreements”.
Under our employment arrangements with each of Messrs. Ellison, Lowe and Gray, in the event that his employment is terminated by us without “cause,” he
may receive severance benefits of up to six months’ base salary. In these instances, we would also pay standard relocation costs to relocate the executive to his previous domicile prior to being relocated to the U.S. Virgin Islands or the Cayman
Islands, as applicable. If any of our executives’ employment is terminated for cause, his employment may be terminated without notice and with no liability to make any further payment to him, other than amounts accrued and unpaid as of the date
of his termination.
Under the terms of their outstanding restricted stock award agreements, each of Messrs. Ellison, Lowe and Gray would have vested, and Mr. Ellison would
have received vesting of common stock with a value of $748,216, Mr. Lowe would have received vesting of common stock with a value of $183,617 and Mr. Gray would have received vesting of common stock with a value of $106,770, based on AAMC’s
closing stock price of $23.58 per share on December 31, 2020.
The Compensation Committee may in its discretion revise, amend or add to the benefits of each executive officer.
None of our executive officers currently has an arrangement in which they would be entitled to a payment on a change of control of AAMC, other than
payments for termination described above to the extent the surviving party in a change of control transaction assumes the employment arrangements described above. Messrs. Ellison, Lowe and Gray also have change in control agreements with Front
Yard that provide for the payment of certain change in control compensation by Front Yard to such NEOs if, within two years of a “Change of Control” of Front Yard (as defined therein), the executive is terminated without “Cause” (as defined
therein) or terminates his employment with us for “Good Reason” (as defined therein). Pursuant to such change in control agreements with Front Yard, the obligation to pay the change in control amount is the obligation of Front Yard, not AAMC.
Such payments would be reduced to the extent of AAMC severance payment amounts described above.
Summary Compensation Table
The following table discloses compensation received by our NEOs for the fiscal years 2019 and 2020:
Name and Principal Position
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
Incentive
Compensation
(3)
|
|
|
All Other
Compensation
(4)
|
|
|
|
|
Indroneel Chatterjee (1)
Chief Executive Officer
|
|
2020
|
|
$
|
649,038(6
|
)
|
|
$
|
800,000(7
|
)
|
|
$
|
786,600(7
|
)
|
|
$
|
636,733(7
|
)
|
|
|
—
|
|
|
$
|
165,625(8
|
)
|
|
$
|
3,037,996
|
|
|
2019
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
George G. Ellison (5)
Former Chief Executive Officer
|
|
2020
|
|
$
|
475,000(9
|
)
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
$
|
947,500(10
|
)
|
|
$
|
107,563(11
|
)
|
|
$
|
1,530,063
|
|
|
2019
|
|
$
|
472,692
|
|
|
|
|
|
|
$
|
1,049,991
|
|
|
|
|
|
|
|
—
|
|
|
$
|
1,395,353
|
|
|
$
|
2,918,036
|
|
Robin N. Lowe
Chief Financial Officer
|
|
2020
|
|
$
|
475,000(12
|
)
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
$
|
350,000(13
|
)
|
|
$
|
58,502(14
|
)
|
|
$
|
883,502
|
|
|
2019
|
|
$
|
472,692
|
|
|
|
|
|
|
$
|
259,596
|
|
|
|
|
|
|
|
—
|
|
|
$
|
89,197
|
|
|
$
|
821,485
|
|
Stephen H. Gray
General Counsel and Secretary
|
|
2020
|
|
$
|
385,000(15
|
)
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
$
|
315,000(16
|
)
|
|
$
|
124,569(17
|
)
|
|
$
|
824,569
|
|
|
2019
|
|
$
|
384,077
|
|
|
|
|
|
|
$
|
149,995
|
|
|
|
|
|
|
$
|
150,000
|
|
|
$
|
448,286
|
|
|
$
|
1,132,358
|
|
(1) |
Mr. Chatterjee joined the company on January 13, 2020 as Co-Chief Executive Officer, and upon resignation of Mr. Ellison on December 29, 2020, became the sole Chief
Executive Officer of the Company.
|
(2) |
Amounts represent the aggregate grant date fair value of restricted shares and option awards granted to our NEOs, calculated in accordance with FASB ASC 718. Such
grant date fair value does not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of restricted shares and option awards are set forth in Note 8 to our Consolidated Financial
Statements for the year ended December 31, 2020 included in our Annual Report. The amount reported in this column reflects the accounting cost for these awards and does not correspond to the actual economic value that may be received by
the directors upon the vesting of the restricted shares, the exercise of the stock options, or any sale of the underlying shares of common stock.
|
(3) |
Consists of the cash annual incentive compensation related to performance in each year and generally awarded in the first quarter of the following year. For example,
non-equity incentive compensation earned in 2020 was paid in January 2021. The non-equity incentive compensation for Messrs. Ellison, Lowe, and Gray were paid in the fourth quarter of 2020, and partially reimbursed by Front Yard
Residential as detailed more fully in the respective footnotes below.
|
(4) |
Consists of contributions from AAMC to each executive officer for relocation expenses, as applicable; supplemental living expenses; car allowances, as applicable;
education allowances, as applicable; travel allowances and medical benefits, as detailed more fully in the respective footnotes below.
|
(5) |
Mr. Ellison resigned as Chief Executive Officer on December 29, 2020.
|
(6) |
The amount reported for 2020 represents Mr. Chatterjee's base salary of $675,000 from his hire date of January 13, 2020, to December 31, 2020.
|
(7) |
The amount reported for 2020 represents Mr. Chatterjee's $800,000 signing bonus, and equity inducement grants consisting of 60,000 shares of service-based restricted
stock with a grant date fair value of $786,600, which was determined based on the average of the high and low sales price of our common stock on the date of the grant, and 60,000 performance-based stock options with a grant date fair
value of $636,733 based on probable achievement. Mr. Chatterjee's signing bonus was paid pursuant to his employment agreement as described above under “Employment Agreements”. The grant date fair value of Mr. Chatterjee's 60,000
performance-based stock options assuming maximum achievement is $3,408,600.
|
(8) |
The amount reported for 2020 includes: $147,315 for supplemental living expenses relating to Mr. Chatterjee's employment in the U.S. Virgin Islands, $17,488 in
medical and life insurance benefits, and $822 for home travel leave expenses.
|
(9) |
Front Yard Residential Corporation reimbursed AAMC for $42,019 of the $475,000 of Mr. Ellison's salary paid in 2020 pursuant to the transition plan associated with
the termination of the amended AMA with Front Yard Residential Corporation.
|
(10) |
The amount in 2020 represents a non-equity cash incentive award to Mr. Ellison of $947,500, of which $722,500 was reimbursed by Front Yard Residential Corporation
pursuant to the transition plan associated with the termination of the amended AMA with Front Yard Residential Corporation.
|
(11) |
The amount reported for 2020 includes $58,485 for supplemental living expenses relating to Mr. Ellison's employment in the U.S. Virgin Islands, $32,584 in medical
insurance benefits, $8,550 of 401(k) employer matching contributions, and $7,943 in relocation costs. Of the $107,563 of other compensation awarded to Mr. Ellison in 2020, $2,965 was reimbursed by Front Yard Residential Corporation
pursuant to the transition plan associated with the termination of the amended AMA with Front Yard Residential Corporation.
|
(12) |
Front Yard Residential Corporation reimbursed AAMC for $42,060 of the $475,000 of Mr. Lowe's salary paid in 2020 pursuant to the transition plan associated with the
termination of the amended AMA with Front Yard Residential Corporation.
|
(13) |
The amount in 2020 represents a non-equity cash incentive award to Mr. Lowe of $350,000, of which $87,500 was reimbursed by Front Yard Residential Corporation
pursuant to the transition plan associated with the termination of the amended AMA with Front Yard Residential Corporation.
|
(14) |
The amount reported for 2020 includes $53,179 for supplemental living expenses under his relocation package for employment in the Cayman Islands, consisting of
$48,000 for supplemental living expenses and $5,179 for Cayman Islands government-required pension benefits, and $5,323 in medical insurance benefits. Of the $58,502 in all other compensation expenses awarded to Mr. Lowe in 2020, $4,000
was reimbursed by Front Yard Residential Corporation pursuant to the transition plan associated with the termination of the amended AMA with Front Yard Residential Corporation.
|
(15) |
Front Yard Residential Corporation reimbursed AAMC for $17,766 of the $385,000 of Mr. Gray's salary paid in 2020 pursuant to the transition plan associated with the
termination of the amended AMA with Front Yard Residential Corporation.
|
(16) |
The amount in 2020 represents a non-equity cash incentive award to Mr. Gray of $315,000, of which $202,500 was reimbursed by Front Yard Residential Corporation
pursuant to the transition plan associated with the termination of the amended AMA with Front Yard Residential Corporation.
|
(17) |
The amount reported for 2020 includes $63,849 for supplemental living expenses relating to Mr. Gray's employment in the U.S. Virgin Islands, $46,470 in medical
insurance benefits, and, $14,250 in 401(k) employer matching contributions. Of the $124,569 in all other compensation expenses awarded to Mr. Gray in 2020, $4,998 was reimbursed by Front Yard Residential Corporation pursuant to the
transition plan associated with the termination of the amended AMA with Front Yard Residential Corporation.
|
Outstanding Equity Awards at 2020 Fiscal Year-End
The following table sets forth information regarding outstanding equity awards held by our NEOs as of December 31, 2020:
|
|
|
|
|
|
|
(a)
|
|
(d)
|
|
|
(e)
|
|
|
(f)
|
|
|
(g)
|
|
|
(h)
|
|
|
|
Equity Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options (#)
|
|
|
Option
Exercise
Price
($)
|
|
|
|
|
|
Number of Shares
or Units of Stock That
Have Not Vested
(#)
|
|
|
Market Value of
Shares or Units of
Stock That Have
Not Vested (1)
($)
|
|
Indroneel Chatterjee
|
|
|
60,000(2
|
)
|
|
$
|
13.11
|
|
|
1/30/2030
|
|
|
|
60,000(3
|
)
|
|
$
|
1,414,800
|
|
George G. Ellison
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
33,571(4
|
)
|
|
$
|
791,604
|
|
Robin N. Lowe
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
7,787(4
|
)
|
|
$
|
183,617
|
|
Stephen H. Gray
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
4,528(4
|
)
|
|
$
|
106,770
|
|
(1) |
Represents the fair market value of the restricted shares as of December 31, 2020, based on the closing price of AAMC’s common stock, as quoted on NYSE American, of
$23.58 per share on December 31, 2020.
|
(2) |
Mr. Chatterjee's performance-based options will be earned based on the achievement of two stock price hurdles. The first tranche of 40,000 performance options is
subject to a hurdle stock price of $52.44, which is four times the $13.11 exercise price (the "First Performance Goal"). Once the First Performance Goal has been attained, 13,333 options will vest and become exercisable immediately, while
an additional 26,667 options will be subject to a time-based service requirement, vesting in equal installments on the first and second anniversary following attainment of the First Performance Goal. The second tranche of 20,000
performance options is subject to a hurdle stock price of $104.88, which is eight times the $13.11 exercise price (the "Second Performance Goal"). Once achieved, 6,666 options will vest and become exercisable immediately, while an
additional 13,334 options will be subject to a time-based service requirement vesting in equal installments on the first and second anniversary following the attainment of the Second Performance Goal. All of the aforementioned vesting
requirements of the inducement performance options are subject to a expiration period ending ten years following the January 30, 2020 grant date.
|
(3) |
Mr. Chatterjee's inducement restricted stock awards are subject to service-based vesting requirements and have or will vest ratably on each of January 30, 2021,
2022, and 2023.
|
(4) |
With respect to the unvested time-based restricted stock for Messrs. Ellison, Lowe, and Gray, 33,571, 7,787, and 4,528 shares vested on or before February 16, 2021,
respectively.
|
Option Exercises
None of our NEOs exercised any options during the year ended December 31, 2020.
Board of Directors Compensation
The following table discloses compensation received by each non-management member of our Board who served as a Director during fiscal year 2020.
Management members of our Board do not receive compensation for their service as a Director.
|
|
Fees Earned
or Paid in Cash
|
|
|
|
|
|
|
|
Ricardo C. Byrd (2)
|
|
$
|
90,000
|
|
|
$
|
59,994
|
|
|
$
|
149,994
|
|
John A. Engerman (2)
|
|
|
90,000
|
|
|
|
59,994
|
|
|
|
149,994
|
|
John P. de Jongh Jr. (2)
|
|
|
115,000
|
|
|
|
59,994
|
|
|
|
174,994
|
|
(1) |
Each of Messrs. Byrd, Engerman, and Gov. de Jongh were granted 2,874 restricted shares of common stock of AAMC on October 13, 2020 for service on the Board. The
number of shares granted was based on a share price of $20.87, which was the average of the high and low sales prices of our common stock on October 13, 2020, and represents the grant date fair value of such shares under FASB ASC 718.
Such grant date fair value does not take into account estimated forfeitures. The amount reported in this column reflects the accounting cost for these restricted shares and does not correspond to the actual economic value that may be
received by the directors upon the vesting of the restricted shares, or any sale of the underlying shares of common stock.
|
(2) |
As of December 31, 2020, each of Messrs. Byrd, Engerman, and Gov. de Jongh held 2,874 unvested shares of time-based restricted stock.
|
On October 13, 2020, Messrs. Byrd and Engram and Governor de Jongh, being the non-management members of the Board serving as of such date, were each
awarded 2,874 shares of restricted stock under the Company’s 2020 Equity Incentive Plan for their service to the Board for the period commencing October 13,2020 to the date of the 2021 Annual Meeting of Stockholders. Upon vesting, each such
Director will receive 2,874 shares of our common stock. Such number of shares was determined by dividing $60,000 by the average of the high and low prices, or $20.87 per share, of AAMC common stock on October 13, 2020 and represents the grant
date fair value calculated in accordance with FASB ASC 718.
Cash Compensation
As set forth above, we provide the following cash compensation to our non-management Directors in quarterly installments, paid in arrears for their
services for the prior quarter:
|
• |
an annual retainer of $75,000;
|
|
• |
an additional $20,000 to the Lead Independent Director of the Board, only if the Chairman of the Board is a management Director (if the Chairman of the Board is a
non-management director, the Chairman shall receive $50,000);
|
|
• |
an additional $20,000 to the Audit Committee chairperson;
|
|
• |
an additional $10,000 to all committee chairpersons (other than the Audit Committee chairperson); and
|
|
• |
an additional $5,000 to all Audit Committee members.
|
Equity Compensation
The 2020 Equity Incentive Plan was approved at the Annual Meeting of Stockholders on October 12, 2020, which supersedes the 2012 Equity Incentive Plan.
The 2020 Equity Incentive Plan is described below in “Equity Compensation Plan Information”. As part of Director compensation, our non-management Directors have received annually restricted shares of common stock of AAMC with a Fair Market Value
of $60,000 pursuant to the 2012 Equity Incentive Plan and 2020 Equity Incentive Plan. “Fair Market Value” is defined as the average of the high and low prices of our common stock as reported on the applicable securities exchange on which AAMC is
listed or quoted on the first day of the service year. Equity compensation is granted for the prior year of service after each annual organizational meeting of the Board, which typically follows the Annual Meeting of Stockholders. Shares of our
common stock will be awarded if the Director attends an aggregate of at least 75% of all meetings of the Board and committees thereof of which the Director is a member during the service year. Grants of restricted shares to our Directors vest on
the date of the Annual Meeting of Stockholders of the following year during which they were granted.
For Directors serving less than a full year, such Directors receive a pro rata portion of $60,000 of restricted shares of our common stock based on the
high and low sales prices on the first day of his or her service year, multiplied by a fraction, the numerator of which is the number of days served and the denominator of which is 365 days.
Other Compensation
Directors are reimbursed for reasonable travel and other expenses incurred in connection with attending meetings of the Board and its committees.
Any Director compensation may be prorated for a Director serving less than a full one (1) year term as in the case of a Director joining the Board after
an Annual Meeting of Stockholders but during the service year.
Compensation Committee Report
The Compensation Committee has reviewed and discussed the information contained in this Item 11 with management. Based on such review and discussions, the
Compensation Committee recommended to the Board that the information contained in this Item 11 be included in the Annual Report on Form 10-K and the Company’s next Proxy Statement.
John Engerman
Governor de Jongh
Ricardo Byrd
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters.
Beneficial Ownership of Common Stock
The following table sets forth certain information regarding the beneficial ownership of our common stock as of March 25, 2021 by:
|
• |
each Director and NEO of the Company;
|
|
• |
all Directors and executive officers of the Company as a group; and
|
|
• |
all persons known by the Company to own beneficially 5% or more of the outstanding common stock.
|
The table is based upon information supplied to us by Directors, executive officers and principal stockholders and filings under the Exchange Act and is
based on an aggregate of 2,048,319 shares issued and outstanding as of March 25, 2021, which does not include 1,359,600 shares held by us in treasury. Unless otherwise indicated, the address of our Directors and executive officers is: Altisource
Asset Management Corporation, 5100 Tamarind Reef, Christiansted, United States Virgin Islands 00820.
Shares Beneficially Owned as of March 25, 2021
Name of Beneficial Owner:
|
|
|
|
|
|
|
William C. Erbey (1)
|
|
|
805,749
|
|
|
|
39.3
|
%
|
Putnam Investments, LLC (2)
|
|
|
337,785
|
|
|
|
16.5
|
%
|
|
|
|
|
|
|
|
Indroneel Chatterjee (3)
|
|
|
58,027
|
|
|
|
2.8
|
%
|
George G. Ellison (4)(5)
|
|
|
85,577
|
|
|
|
4.2
|
%
|
Robin N. Lowe (6)
|
|
|
33,300
|
|
|
|
1.6
|
%
|
Stephen H. Gray (7)
|
|
|
5,093
|
|
|
|
*
|
|
Chris Moltke-Hansen
|
|
|
4,774
|
|
|
|
*
|
|
P. Graham Singer
|
|
|
5,303
|
|
|
|
*
|
|
Ricardo C. Byrd (8)
|
|
|
10,127
|
|
|
|
*
|
|
John A. Engerman (8)
|
|
|
7,105
|
|
|
|
*
|
|
John P. de Jongh, Jr. (8)
|
|
|
7,967
|
|
|
|
*
|
|
All Directors and Executive Officers as a Group (6 persons) (9)
|
|
|
217,273
|
|
|
|
10.6
|
%
|
(1) |
Based on information contained in a Schedule 13D/A filed by Mr. Erbey on May 20, 2019, a Form 4 filed by Mr. Erbey on May 31, 2019 and a Form 4 filed by Mr. Erbey on
June 3, 2019. Includes: (a) 26,293 shares of common stock held by the Carisma Trust, a Nevada trust, the trustee of which is Venia, LLC, a Nevada limited liability company (“Venia”) and (b) 696,029 shares of common stock held by Salt Pond
Holdings, LLC, a U.S. Virgin Islands limited liability company (“Salt Pond”) of which the Christiansted Trust, a U.S. Virgin Islands trust (the “C-Trust”), the Frederiksted Trust, a U.S. Virgin Islands trust (the “F-Trust”), and Erbey
Holding Corporation, Inc., a Delaware corporation (“Erbey Holding”) are members. Erbey Holding is wholly owned by the Carisma Trust, the trustee of which is Venia (together with Mr. Erbey, E. Elaine Erbey (“Mrs. Erbey”), Erbey Holding,
Salt Pond, the C-Trust, the F-Trust and the Carisma Trust, the “Reporting Persons”). The members of Venia are Mrs. Erbey, John Erbey (Mr. Erbey’s brother) and Andrew Burnett, although Mr. Erbey is given sole investment and voting control
over any securities owned by Venia or the Carisma Trust. Mr. Erbey, John Erbey, Mrs. Erbey and Salt Pond are co-trustees of the C-Trust. Mr. Erbey, John Erbey, and Salt Pond are co-trustees of the F-Trust. Mr. Erbey, Erbey Holding, the
C-Trust, the F-Trust, the Carisma Trust and Venia each may be deemed to beneficially own the 696,029 shares of common stock held by Salt Pond.
|
(2) |
Based on information contained in a Schedule 13G/A jointly filed with the SEC on March 10, 2021 by Putnam Investments, LLC, Putnam Investment Management, LLC, the
Putnam Advisory Company, LLC and Putnam Focused Equity Fund (collectively, “Putnam”). Includes zero shares as to which sole voting power is claimed, 337,785 shares as to which sole dispositive power is claimed and zero shares as to which
shared voting power and shared dispositive power is claimed. Putnam’s address is 100 Federal Street, Boston, Massachusetts 02110.
|
(3) |
Mr. Chatterjee also owns 100 shares of Series L Preferred Stock, which are excluded from the table above because such shares are not transferable and have no voting
power.
|
(4) |
Mr. Ellison resigned as Chief Executive Officer on December 29, 2020.
|
(5) |
Based on information contained in a Form 4 filed by Mr. Ellison on October 14, 2020.
|
(6) |
Based on information contained in a Form 4 filed by Mr. Lowe on February 21, 2020.
|
(7) |
Based on information contained in a Form 4 filed by Mr. Gray on October 14, 2020.
|
(8) |
Includes 2,874 shares issuable to each of Messrs. Byrd and Engerman and Governor de Jongh for service on our Board for the 2020 to 2021 service year that vest within
60 days after March 25, 2021.
|
(9) |
Includes Messrs. Chatterjee, Moltke-Hansen, Singer, Byrd, Engerman, and Governor de Jongh. Does not include an aggregate of 60,000 stock options granted to Mr.
Chatterjee or 50,000 restricted shares of common stock granted to Messrs. Chatterjee, Moltke-Hansen and Singer because such stock options or restricted shares do not become exercisable or vest, respectively, within 60 days after March
25, 2021.
|
Equity Compensation Plan Information
The following table sets forth information as December 31, 2020 with respect to compensation plans under which our equity securities are authorized for
issuance (other than the 2016 Employee Preferred Stock Plan).
|
|
Number of Securities
to be Issued upon
Exercise of
Outstanding Options,
Warrants and Rights
(a)
|
|
|
Weighted-Average
Exercise Price of
Outstanding Options,
Warrants and Rights
(b)
|
|
|
Number of Securities
Remaining Available for
Future Issuance under Equity
Compensation Plans
(Excluding Securities Reflected
in Column (a))
(c)
|
|
|
|
Equity Compensation Plans Approved by Security Holders:
|
|
2012 Equity Incentive Plan
|
|
|
118,982
|
|
|
$
|
4.01
|
|
|
|
2,442
|
|
2012 Special Equity Incentive Plan
|
|
|
—
|
|
|
$
|
—
|
|
|
|
—
|
|
2020 Equity Incentive Plan
|
|
|
—
|
|
|
$
|
—
|
|
|
|
166,378
|
|
|
|
Equity Compensation Plans Not Approved by Security Holders:
|
|
Indroneel Chatterjee (1)
|
|
|
60,000
|
|
|
$
|
13.11
|
|
|
|
60,000
|
|
Total
|
|
|
187,013
|
|
|
$
|
7.06
|
|
|
|
228,820
|
|
(1) |
As approved in connection with his appointment as our Co-Chief Executive Officer on January 13, 2020, Mr. Chatterjee was granted inducement equity awards that were
made outside of our 2012 Equity Incentive Plan but are otherwise subject to the terms and conditions of the 2012 Equity Incentive Plan. Such initial equity award qualified as “inducement awards” for purposes of the NYSE American's
exemption from stockholder approval requirements for inducement awards. The equity awards consisted of options to purchase 60,000 shares of common stock and 60,000 restricted shares. The options are subject to vesting following the
achievement of certain trading price targets and further time-based vesting criteria thereafter. The restricted shares will vest annually over a three-year period following the grant date of January 30, 2020.
|
The Equity Incentive Plans allow for grants to be made in a number of different forms, including but not limited to options, restricted stock, restricted
stock units and stock appreciation rights. We granted options to purchase our common stock to the option holders of Altisource Portfolio Solutions S.A. (“ASPS”) under the 2012 Equity Plan and the 2012 Special Equity Incentive Plan in connection
with the separation from ASPS. Other than the grant of these options, we have granted restricted shares of common stock under the 2020 Equity Incentive Plan, 2012 Equity Incentive Plan, and 2012 Special Equity Incentive Plan subject to the
vesting requirements described in “Compensation Discussion and Analysis - Equity Incentive Plans.” We do not expect to grant any additional options or restricted shares under the 2012 Special Equity Incentive Plan, which was limited to the grants
on or prior to our separation from ASPS; all grants made after our separation from ASPS were made out of our 2012 Equity Incentive Plan. We have also issued shares of common stock to our non-management Directors in connection with their service
on our Board as described above in “Director Compensation.”
On January 30, 2020, as approved in connection with his appointment as our Co-Chief Executive Officer on January 13, 2020, Mr. Chatterjee was granted
inducement equity awards that were made outside of our 2012 Equity Incentive Plan but are otherwise subject to the terms and conditions of the 2012 Equity Incentive Plan. Such initial equity award qualified as “inducement awards” for purposes of
the NYSE American's exemption from stockholder approval requirements for inducement awards. The equity awards consisted of options to purchase 60,000 shares of common stock and 60,000 restricted shares. The options are subject to vesting
following the achievement of certain trading price targets and further time-based vesting criteria thereafter. The restricted shares will vest annually over a three-year period following the date of grant.
Item 13
. Certain Relationships and Related Transactions, and Director Independence.
Related Party Transaction Policy
The Board has adopted policies and procedures for the review, approval and monitoring of transactions involving AAMC and related persons (Directors,
nominees for election as Director and NEOs or their immediate family members or stockholders owning 5% or greater of the Company’s outstanding stock or their immediate family members) within our written Code of Business Conduct and Ethics, which
is available at www.altisourceamc.com. The policies and procedures are not limited to related person transactions that meet the threshold for disclosure under the relevant SEC rules as the policies and procedures broadly cover any situation in
which a conflict of interest may arise.
Any situation that potentially involves a conflict of interest is to be immediately disclosed to the Company’s General Counsel who, in consultation with
management and the Audit Committee chair and with outside counsel, as appropriate, must assess the nature and extent of any concern and then recommend any follow up action, as needed. The General Counsel will notify the Chair of the Audit
Committee if any such situation requires notice to or approval of the Audit Committee of the Board of Directors.
Related persons are required to obtain the approval of the Audit Committee of the Board for any transaction or situation that may pose a conflict of
interest. In considering a transaction, the Audit Committee will consider all relevant factors including, but not limited to, (i) whether the transaction is in the best interests of AAMC; (ii) alternatives to the related-person transaction; (iii)
whether the transaction is on terms comparable to those available to third parties; (iv) the potential for the transaction to lead to an actual or apparent conflict of interest and any safeguards imposed to prevent such actual or apparent
conflicts; and (v) the overall fairness of the transaction to AAMC.
On March 31, 2015, we entered into an asset management agreement (the “Former AMA”), under which we were the exclusive asset manager for Front Yard an
initial term of 15 years from April 1, 2015, with two potential five-year extensions. The Former AMA provided for a fee structure in which AAMC was entitled to a base management fee, an incentive management fee and a conversion fee for mortgage
loans and REO properties that become rental properties for the first time during each quarter.
On May 7, 2019, we entered into an amended and restated asset management agreement (the “Amended AMA”), under which we are Front Yard’s exclusive asset
manager for an initial term of five years. The Amended AMA was eligible to renew automatically each year thereafter for an additional one-year term, subject in each case to certain termination provisions. The Amended AMA provided for a fee
structure in which AAMC was entitled to a base management fee and a potential incentive fee.
On August 13, 2020, the Company entered into a Termination Agreement with Front Yard and Front Yard Residential L.P. (“FYR LP”) to terminate the Amended
AMA and to provide for a transition plan to facilitate the internalization of Front Yard’s asset management function (the “Transition Plan”). Pursuant to the terms of the Termination Agreement, effective December 31, 2020, the date that the
parties mutually agreed that the Transition Plan had been satisfactorily completed (the “Termination Date”), the Amended AMA was terminated in its entirety. See “Termination and Transition Agreement with Front Yard” below for more information on
the termination of the Amended AMA and the Transition Plan.
For additional information regarding our asset management agreements with Front Yard, refer to Note 6, “Related-Party Transactions” of the consolidated
financial statements included within the Company's 2020 Annual Report filed with the SEC on March 3, 2021.
Aggregate Management Fees and Expense Reimbursements Paid to AAMC by Front Yard in 2020
In 2020, the aggregate fees paid to AAMC under the asset management agreements by Front Yard were $13,712,696 in management fees and $2,866,933 in expense
reimbursements, and $46,000,000 in termination fees.
No Incentive Management Fee under the Former AMA was payable to us during 2020 because Front Yard's return on invested capital (as defined in the Former
AMA) for the previous seven quarters was below the required hurdle rate.
No incentive fees were paid by Front Yard to AAMC under the Amended AMA.
Termination and Transition Agreement with Front Yard
On August 13, 2020, the Company entered into a Termination Agreement with Front Yard and FYR LP to terminate the Amended AMA and to provide for a
Transition Plan.
Pursuant to the terms of the Termination Agreement, effective on the Termination Date, the Amended AMA was terminated in its entirety.
In connection with the Termination Agreement, the Company was paid by Front Yard an aggregate termination fee (the “Termination Fee”) of $46,000,000, with
payments consisting of $15,000,000 in cash paid within two business days after the execution of the Termination Agreement, $15,000,000 in cash paid on the Termination Date and $16,000,000 in Front Yard common stock (“Common Stock”), paid on the
Termination Date. During the transition period, the Company continued to be paid the base management fee provided for in the AMA (equal to $3,584,000 per quarter as contemplated by the Amended AMA) and a pro rata portion of the base management
fee for the partial calendar quarter ending December 31, 2020, the date Front Yard determined that the transition had been satisfactorily completed.
In addition, in connection with the termination, the Company transferred to Front Yard, the equity interests of the Company’s Indian subsidiary, the
equity interests of the Company’s Cayman Islands subsidiary, the right to solicit and hire designated employees of the Company that currently oversee the management of Front Yard’s business and other assets of the Company that are used in
connection with the operation of Front Yard’s business (the “Transferred Assets”). The aggregate purchase price (the “Purchase Price”) for the Transferred Assets was $8,200,000, with payments consisting of $3,200,000 in cash paid within two
business days after the execution of the Termination Agreement and $5,000,000 in Common Stock, paid on the Termination Date. The Company was provided and executed the right to retain certain employees that do not currently oversee the management
of Front Yard’s business and the right to solicit and retain certain other designated employees of the Company. In addition to the retention of such key employees, the Company retained certain assets and operating subsidiaries to continue to
build out its asset management businesses focused on the origination and underwriting of short duration construction loans backed by single-family rental homes as well as other new business initiatives.
For the portion of the Termination Fee or Purchase Price that was paid in Common Stock, the value of each share of Common Stock was the volume-weighted
average share price, as determined by reference to a Bloomberg terminal, of Common Stock for the five business days immediately preceding the date on which such portion is actually paid, which was $16.17 per share. In addition, for the portion of
the Termination Fee or Purchase Price that was paid in Common Stock, the Company agreed to vote any such shares of Common Stock in accordance with recommendations of Front Yard’s board of directors for a period of one year following the
Termination Date.
The Termination Agreement contains various covenants, including, among others, that until the Termination Date, the Company perform its obligations under
the Amended AMA and manage the business of the Front Yard and its subsidiaries in the ordinary course of business consistent with past practice, except as otherwise directed by the board of directors of Front Yard in accordance with the Amended
AMA.
The foregoing description of the Termination Agreement does not purport to be complete and is subject to and qualified in its entirety by reference to the
full text of the Termination Agreement, which is filed as
Exhibit 10.1 to the Company’s
Current Report on Form 8-K, filed with the SEC on August 18, 2020, and is incorporated herein by reference.
Equity Plans
Options Granted in Separation from ASPS
In connection with our separation from ASPS in December 2012, we adopted the 2012 Equity Plan. In the separation transaction, we issued options to
purchase 242,771 shares of our common stock with a weighted average exercise price of $1.52 per share at December 31, 2012 under the 2012 Equity Plan to ASPS employees holding ASPS stock options immediately prior to the separation, representing
the same exchange ratio as the separation transaction of one share for every ten shares represented by the ASPS options. These options expire on the same dates as they expired under the ASPS plans. Because the options were granted as part of the
separation to holders of ASPS stock options, no share-based compensation related to these options is included in our consolidated financial statements appearing in our 2020 Annual Report. None of these options have ever been held by, or were
exercised by, any of our NEOs. No additional shares of common stock are issuable under the 2012 Equity Plan other than shares of restricted stock issuable to our Directors and employees.
Item 14
. Principal Accountant Fees and Services.
The following table shows the aggregate fees billed to AAMC for professional services by Ernst & Young LLP with respect to our fiscal year ended
December 31, 2020 and 2019:
|
|
|
|
|
|
|
Audit Fees
|
|
$
|
468,950
|
|
|
$
|
450,666
|
|
Audit-Related Fees
|
|
|
—
|
|
|
|
—
|
|
Tax Fees
|
|
|
17,546
|
|
|
|
46,957
|
|
All Other Fees
|
|
|
—
|
|
|
|
—
|
|
Total
|
|
$
|
486,496
|
|
|
$
|
497,623
|
|
Audit Fees. This category includes the aggregate fees
and expenses billed for professional services rendered for the audits of AAMC’s consolidated financial statements for the fiscal years ended December 31, 2020 and 2019, for reviews of the financial statements included in AAMC’s quarterly reports
on Form 10-Q during those fiscal years and for services that are normally provided by the independent registered public accounting firm and affiliates in connection with statutory and regulatory filings or engagements for the relevant fiscal
year.
Audit-Related Fees. This category includes the
aggregate fees billed for audit-related services by the independent registered public accounting firm that are reasonably related to the performance of the audits or reviews of the financial statements and are not reported above under “Audit
Fees.”
Tax Fees. This category would include the aggregate
fees billed for professional services rendered by the independent registered public accounting firm for tax compliance and tax planning.
All Other Fees. This category would include the
aggregate fees billed for products and services provided by the independent registered public accounting firm that are not reported above under “Audit Fees,” “Audit-Related Fees” or “Tax Fees.” We did not incur any such other fees for the years
ended December 31, 2020 and 2019.
The Audit Committee considered the fees paid to Ernst & Young LLP for the fiscal year ended December 31, 2020 and determined that the services and
fees are compatible with the independence of Ernst & Young LLP.
Audit Committee Pre-Approval Policy
The Audit Committee is required to pre-approve the audit and (unless the de minimus exception of applicable law permits) non-audit services performed by
the independent registered public accounting firm in order to assure that the provision of such services does not impair the independent registered public accounting firm’s independence. Unless a type of service to be provided by the independent
registered certified public accounting firm has received general pre-approval, it will require specific pre-approval by the Audit Committee. For the fiscal years ended December 31, 2020 and 2019, all fees associated with the independent
registered public accounting firm’s services were pre-approved by the Audit Committee.
The Audit Committee may delegate pre-approval authority to one or more of its members. The member or members to whom such authority is delegated will
report any pre-approval decisions to the Audit Committee at its next scheduled meeting. The Audit Committee does not delegate its responsibilities to pre-approve services performed by the independent registered public accounting firm to
management.
The exhibits listed below are filed with this Amendment and the exhibits listed in Item 15 of the Original Form 10-K are hereby incorporated by reference in this Amendment.
Exhibit
Number
|
|
Description
|
|
|
Certification of Interim Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act
|
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
|
|
Altisource Asset Management Corporation
|
|
|
|
Date:
|
April 30, 2021
|
By:
|
/s/ Thomas K. McCarthy
|
|
|
|
Thomas K. McCarthy
|
|
|
|
Interim Chief Executive Officer
|
26